To compare the effectiveness of Janus kinase inhibitors (JAKis) and biologic disease-modifying anti-rheumatic drugs (bDMARDs) on pain in patients with rheumatoid arthritis (RA).
No takes yet. Share an insight, caveat, or question.
Eberhard et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: